The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWarpaint London Regulatory News (W7L)

Share Price Information for Warpaint London (W7L)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 462.50
Bid: 460.00
Ask: 465.00
Change: 0.00 (0.00%)
Spread: 5.00 (1.087%)
Open: 465.00
High: 465.00
Low: 460.00
Prev. Close: 460.00
W7L Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ward & Hagon Contract Renewal

1 Feb 2024 07:00

RNS Number : 6047B
Warpaint London PLC
01 February 2024
 

1 February 2024

 

Warpaint London PLC

("Warpaint", the "Company" or the "Group")

 

Ward & Hagon Contract Renewal

 

Warpaint London plc (AIM: W7L), the specialist supplier of colour cosmetics and owner of the W7 and Technic brands, announces that on 31 January 2024, it renewed its contract (the "Contract") with Ward & Hagon Management Consulting LLP ("Ward & Hagon") for a period of 24 months, effective 1 January 2024. At the end of the 24 month period, the Contract will continue on the same terms subject to a six month notice period which can be served by either party.

 

The Company originally appointed Ward & Hagon, a provider of practical business solutions, in February 2020 to assist it in implementing its strategic growth plan. The contract was renewed on 19 February 2021 for a period of 12 months and was again renewed on 1 March 2022 for a period of 24 months effective from 1 January 2022. The objective of the Contract renewal is to continue to accelerate Warpaint's growth and drive further business transformation.

 

The Contract has a total fixed value over 24 months of £450,000 (£225,000 per annum) and includes the services of Paul Hagon, an executive director of the Company and Martyn Ward, together with other members of the Ward & Hagon team. In addition, Ward & Hagon has an opportunity under the Contract to earn up to £175,000 per annum through non-discretionary performance related sales bonuses and commissions. Payments under the Contract will be satisfied from the Group's operating cash flows.

 

The Board is of the view that Ward & Hagon has been important to the Group's success over the last few years and the services provided under the Contract represent good value to shareholders.

 

 

Related Party Transaction

 

Paul Hagon, an executive director of Warpaint, is a member of Ward & Hagon. Accordingly the renewal of the Contract is classified as a related party transaction pursuant to the AIM Rules for Companies. The independent directors of the Company (being all executive and non-executive directors except Mr Hagon), having consulted with Shore Capital, the Company's Nominated Adviser, consider that the terms of the Contract renewal are fair and reasonable insofar as the Company's shareholders are concerned.

 

Enquiries:

Warpaint London

Sam Bazini - Chief Executive Officer

Eoin Macleod - Managing Director

Neil Rodol - Chief Financial Officer

 

c/o IFC

 

Shore Capital (Nomad and Broker)

Patrick Castle, Daniel Bush - Corporate Advisory

Fiona Conroy - Corporate Broking

 

 

020 7408 4090

IFC Advisory (Financial PR & IR)

Tim Metcalfe, Graham Herring, Florence Chandler

020 3934 6630

 

 

Warpaint London plc

 

Warpaint sells branded cosmetics under the lead brand names of W7 and Technic. W7 is sold in the UK primarily to retailers and internationally to local distributors or retail chains. The Technic brand is sold in the UK and continental Europe with a significant focus on the gifting market, principally for high street retailers and supermarkets. In addition, Warpaint supplies own brand white label cosmetics produced for several major high street retailers. The Group also sells cosmetics using its other brand names of Man'stuff, Body Collection, Very Vegan, and Chit Chat.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTEAPFFDFALEFA
Date   Source Headline
15th Jun 20207:00 amRNSEquity Development Investor Webinar
1st Jun 20204:36 pmRNSPrice Monitoring Extension
1st Jun 20202:00 pmRNSNotice of AGM and Posting of Annual Report
1st Jun 20207:00 amRNSFurther UK Retail Expansion
21st May 20207:00 amRNSShare Option Plan, Grant of Options & PDMR Holding
13th May 20207:00 amRNSFinal Results for the year ended 31 December 2019
11th May 20204:29 pmRNSHolding(s) in Company
29th Apr 20204:35 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSCovid-19 Update and Notice of Results
19th Mar 20207:00 amRNSUpdate regarding Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:38 pmRNSPrice Monitoring Extension
18th Mar 20202:06 pmRNSSecond Price Monitoring Extn
18th Mar 20202:01 pmRNSPrice Monitoring Extension
6th Feb 20207:00 amRNSUK Retail Expansion & Trading Update
20th Dec 20197:00 amRNSTrading Update
16th Oct 20194:28 pmRNSDirector Dealings
24th Sep 20197:08 amRNSHolding(s) in Company
20th Sep 20192:25 pmRNSHolding(s) in Company
18th Sep 20197:00 amRNSInterim Results for the six months to 30 June 2019
19th Aug 20197:00 amRNSAppointment of Joint Broker
6th Aug 20197:00 amRNSTrading Update and Notice of Results
11th Jun 20197:00 amRNSChange of Adviser
21st May 20191:54 pmRNSHolding(s) in Company
21st May 201911:55 amRNSResult of AGM
21st May 201910:59 amRNSAGM Statement
26th Apr 20192:10 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20193:13 pmEQSHardman & Co Research: Warpaint London Plc (W7L): FY'18 sales: remains profitable despite weak UK market
10th Apr 20197:00 amRNSResults for the 12 months ended 31 December 2018
3rd Apr 20197:00 amRNSNotice of Results
11th Mar 20193:19 pmRNSHolding(s) in Company
22nd Feb 20194:21 pmRNSHolding(s) in Company
20th Feb 201912:58 pmRNSHolding(s) in Company
29th Jan 20197:00 amRNSTrading Update
1st Nov 201812:45 pmEQSHardman & Co Research: Warpaint London Plc (W7L): Trading update: softening UK market
31st Oct 20187:00 amRNSHolding(s) in Company
30th Oct 201811:52 amRNSDirector Dealings
29th Oct 20189:05 amRNSSecond Price Monitoring Extn
29th Oct 20189:00 amRNSPrice Monitoring Extension
29th Oct 20187:00 amRNSTrading Update
4th Oct 20185:30 pmEQSHardman & Co Research: Warpaint London Plc (W7L): 1H'18 interims: delivering the results
4th Oct 20185:10 pmEQSHardman & Co Research: Diurnal Group (DNL): First commercial revenues
24th Sep 20187:00 amRNSImplementation of Long-term Incentive Plan
21st Sep 20184:37 pmRNSHolding(s) in Company
17th Sep 20187:00 amRNSAppointment of Director
17th Sep 20187:00 amRNSInterim Results for the 6 months to 30 June 2018
3rd Sep 20187:00 amRNSNotice of Results
3rd Aug 20187:00 amRNSAcquisition of USA Distributor
19th Jun 20187:00 amRNSDirector Dealings
13th Jun 20182:43 pmEQSHardman & Co Research: Warpaint London PLC (W7L): Painting a bright future

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.